MNKD-101

N/A

Report date: 2024/04/30 13:52:29

Base Information

Drug NameMNKD-101
Drug Alias NameClofazimine Inhalation SuspensionMNKD-101QRM-003QRM-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsMycobacterium Infections, Nontuberculous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMannKind Corp
China Registration ClassN/A

Develop Information

Active CompaniesMannKind Corp
Inactive CompaniesN/A
Active IndicationsMycobacterium Infections, Nontuberculous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A